(Q39016680)

8 September 2017

title

MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer (English)

1 reference

8 September 2017

1 reference

1 reference

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24615544%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Wen-Dong Bai

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24615544%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Xing-Ming Ye

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24615544%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Meng-Yao Zhang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24615544%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Hua-Yu Zhu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24615544%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Wen-Jin Xi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24615544%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Xun Huang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24615544%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Jiao Zhao

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24615544%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Bin Gu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24615544%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Guo-Xu Zheng

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24615544%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

An-Gang Yang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24615544%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

language of work or name

English

0 references

publication date

3 March 2014

1 reference

International Journal of Cancer

8 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24615544%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24615544%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24615544%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

1356-1368

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24615544%20AND%20SRC:MED&resulttype=core&format=json

Trastuzumab--mechanism of action and use in clinical practice

9 June 2020

cites work

1 reference

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer

21 January 2018

1 reference

Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population.

21 January 2018

1 reference

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

21 January 2018

1 reference

Cancer early dissemination: cancerous epithelial-mesenchymal transdifferentiation and transforming growth factor β signalling

21 January 2018

1 reference

MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling

21 January 2018

1 reference

The Functional Crosstalk between HER2 Tyrosine Kinase and TGF-β Signaling in Breast Cancer Malignancy

21 January 2018

1 reference

21 January 2018

1 reference

ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invasion

21 January 2018

1 reference

Epithelial-mesenchymal transition: a cancer researcher's conceptual friend and foe.

21 January 2018

1 reference

The long and short of microRNA.

21 January 2018

1 reference

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

21 January 2018

1 reference

Functional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition

21 January 2018

1 reference

Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer

21 January 2018

1 reference

Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy

21 January 2018

1 reference

Induction of colonies of hemoglobin-synthesizing cells by erythropoietin in vitro

21 January 2018

1 reference

Pretreatment tumor diameter/volume and pelvic lymph node status assessed by magnetic resonance imaging for uterine cervical carcinoma treated with concurrent chemotherapy and radiotherapy.

21 January 2018

1 reference

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

21 January 2018

1 reference

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

21 January 2018

1 reference

A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells

21 January 2018

1 reference

New insights into the mechanisms of organ-specific breast cancer metastasis

21 January 2018

1 reference

Reduced in vivo lung metastasis of a breast cancer cell line after treatment with Herceptin mAb conjugated to chemotherapeutic drugs

21 January 2018

1 reference

Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors

21 January 2018

1 reference

Epithelial-mesenchymal transitions in development and disease

21 January 2018

1 reference

Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells.

21 January 2018

1 reference

TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer

21 January 2018

1 reference

Expression of Wnt3 activates Wnt/β-catenin pathway and promotes EMT-like phenotype in trastuzumab-resistant HER2-overexpressing breast cancer cells

21 January 2018

1 reference

Spontaneous epithelial-mesenchymal transition and resistance to HER-2-targeted therapies in HER-2-positive luminal breast cancer

21 January 2018

1 reference

MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1

21 January 2018

1 reference

Control of metastatic progression by microRNA regulatory networks

21 January 2018

1 reference

MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer

21 January 2018

1 reference

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

21 January 2018

1 reference

Development of therapeutic combinations targeting major cancer signaling pathways

21 January 2018

1 reference